You just read:

Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira Sales Practices

News provided by

Hagens Berman Sobol Shapiro LLP

Nov 09, 2018, 18:24 ET